| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 12/19/2007 | CN101088520A Medicine composition for auxiliary treatment of cancer and its prepn and quality control method |
| 12/19/2007 | CN101088469A Diabetes management methods and systems |
| 12/19/2007 | CN100356168C Method and apparatus for improving blood measurement reliability using multi-channel circuit |
| 12/19/2007 | CN100356167C Biological sensor and testing method therewith |
| 12/19/2007 | CN100355905C Improved binding interactions in dipstick assays |
| 12/19/2007 | CN100355904C Extracellular potential sensing element, device for measuring extracellular potential, apparatus for measuring extracellular potential and method of measuring extracellular potential by using the same |
| 12/19/2007 | CN100355887C Method for obtaining target mDNA |
| 12/19/2007 | CN100355785C Process for selectively separating IgY antibody from anseriforme birds eggs and IgY antibody produced therefrom |
| 12/18/2007 | US7310544 Methods and systems for inserting a transcutaneous analyte sensor |
| 12/18/2007 | US7309858 Method and apparatus for de-convoluting a convoluted spectrum |
| 12/18/2007 | US7309857 Gamma ray detectors having improved signal-to-noise ratio and related systems and methods for analyzing materials in an oil well |
| 12/18/2007 | US7309812 Mating a transgenic mouse whose genome encodes mouse perlecan, a large multidomain proteoglycan that binds and cross-links extracellular matrix (ECM) components and cell surface molecules, domains, with a second transgenic mouse whose genome encodes the human C terminal of A beta precursor protein |
| 12/18/2007 | US7309811 Animal model for use in diagnosisng and treating nervous system disorders |
| 12/18/2007 | US7309810 Nonhuman model animal suffering from Guillain-Barré syndrome and/or fisher syndrome |
| 12/18/2007 | US7309778 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/18/2007 | US7309777 Antibodies against the PRO1556 polypeptide |
| 12/18/2007 | US7309776 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative and tumor disorders |
| 12/18/2007 | US7309771 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of tumors |
| 12/18/2007 | US7309769 PRO1487 polypeptides |
| 12/18/2007 | US7309768 PRO4347 polypeptides |
| 12/18/2007 | US7309767 Used as pharmaceuticals, diagnostics, biosensors and bioreactors |
| 12/18/2007 | US7309765 PRO4349 polypeptides |
| 12/18/2007 | US7309764 PRO4401 polypeptide |
| 12/18/2007 | US7309763 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders |
| 12/18/2007 | US7309760 Repeat sequences of the CA125 gene and their use for diagnostic and therapeutic interventions |
| 12/18/2007 | US7309759 Indolicidin peptide analogues containing at least two basic amino acids; bactericide |
| 12/18/2007 | US7309615 High quantum yield acridinium compounds and their uses in improving assay sensitivity |
| 12/18/2007 | US7309614 Colorimetric resonant optical biosensors, for detecting biomolecular interactions, without the use of labels and can be done in a high-throughput manner |
| 12/18/2007 | US7309611 Lateral flow adsorption membranes adapted to receive a buffer that prewets the membrane and receive a sample which flows within the prewet membrane for use in quantitative analysis of cells and analytes in fluid |
| 12/18/2007 | US7309608 Method of analysis of aldehyde and ketone by mass spectrometry |
| 12/18/2007 | US7309607 Blood is drawn through a passageway, such as a catheter, past or against an obstruction or irregularity in the passageway, such as a wire placed in the catheter; platelets adhere and aggregate on the obstruction or on the wall of the passageway near the obstruction or irregularity, form a platelet mass |
| 12/18/2007 | US7309604 Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins |
| 12/18/2007 | US7309595 Comprises protease for use in generating proline rich protein hydrolysate for use in food and drink to decrease allergenicity, facilitate gastrointestinal uptake and to stabilize proteins in acid products against precipitation during prolonged storage |
| 12/18/2007 | US7309593 Attachment of molecules to surfaces |
| 12/18/2007 | US7309587 Process for producing β 1,3-N-acetylglucosaminyl-transferase and N-acetylglucosamine-containing complex carbohydrate |
| 12/18/2007 | US7309585 Protein, therapy, diagnosis of cancer, to elicit an immune response |
| 12/18/2007 | US7309579 Finding chemical substances which stimulate the activity of a soluble guanylate cyclase when the heme iron of at least part of this soluble guanylate cyclase is oxidized to the trivalent state |
| 12/18/2007 | US7309578 Administering an antagonist inhibiting apoptosis of lung cells, diagnosing the disease |
| 12/18/2007 | US7309577 G-protein protein coupled receptor fusion for use as tool in enhancing food taste; flavoring |
| 12/18/2007 | US7309576 Transfecting a eukaryotic cell with nucleotide sequence, contacting cell with a candidate compound; determining distribution of expressed protein in cell by detecting the distribution of detectable moiety in cell |
| 12/18/2007 | US7309575 Purifying target proteins using post-synaptic density 95, discs-large and zonular occludens (PDZ1) domain and a no receptor potential A (NorpA) sequence soluble matrix |
| 12/18/2007 | US7309572 Growth hormone-regulatable liver genes and proteins, and uses thereof |
| 12/18/2007 | US7309567 Method for reducing fluorescence quenching in bioassays |
| 12/18/2007 | US7309566 Using biotinylated single chain fragment of variable antibodyies to detect and prevent viral infection. |
| 12/18/2007 | US7309525 Inorganic nanocrystals with organic coating layer, their method of manufacture and materials constituted by said nanocrystals |
| 12/18/2007 | US7309485 Oligodendrocyte-myelin glycoprotein (OMgp)-specific binding agents, receptor binding assays; promoting nerve fiber growth |
| 12/18/2007 | US7309458 Multi-sided immersion formation of composite structures and method |
| 12/18/2007 | US7309439 To transport microbeads for performing chemical and biochemical reactions or assay, clinical chemistry assays for medical diagnostic purposes |
| 12/18/2007 | US7309418 Water contaminant indicators |
| 12/18/2007 | US7309020 Deposition fabrication using inkjet technology |
| 12/18/2007 | US7308913 Liquid filling method, liquid filling apparatus, and discharge apparatus |
| 12/18/2007 | US7308818 Impact-sensing and measurement systems, methods for using same, and related business methods |
| 12/18/2007 | CA2406036C Pathology grossing board |
| 12/18/2007 | CA2369802C Particle quantifying apparatus and method |
| 12/18/2007 | CA2322118C Method for optimizing drill bit and drilling parameter selection using rock strength measurements made from drill cuttings |
| 12/18/2007 | CA2217074C Process for detecting target nucleic acid, process for quantifying the same, and pyrylium compound for chemiluminescence analysis |
| 12/18/2007 | CA2188727C Thermostable alkaline phosphatase of rhodothermus marinus |
| 12/18/2007 | CA2179562C Peptide useful in the separation and purification of immunoglobulins |
| 12/18/2007 | CA2173156C A method for characterizing polymer molecules or the like |
| 12/18/2007 | CA1341566C Immune response to tumors induced by anti-idiotype antibodies |
| 12/14/2007 | CA2549124A1 Method and a kit for the detection of adenoviruses |
| 12/14/2007 | CA2547901A1 Chronic lymphocytic leukaemia |
| 12/13/2007 | WO2007143615A2 Systems and methods for performing measurements of one or more analytes comprising using magnetic particles and applying a magnetic field |
| 12/13/2007 | WO2007143574A1 Protein surface remodeling |
| 12/13/2007 | WO2007143561A1 Immunity to folate receptors |
| 12/13/2007 | WO2007143543A1 System and method for estimating oxygen concentration in a mixed gas experiencing pressure fluctuations |
| 12/13/2007 | WO2007143183A2 Methods for developing and assessing therapeutic agents |
| 12/13/2007 | WO2007143161A2 Use of proteins and peptides of the tgf-beta superfamily for purification and therapeutic methods |
| 12/13/2007 | WO2007143112A2 Methods for diagnosing disorders and diseases associated with ryanodine receptors and methods for identifying compounds that affect ryanodine receptors |
| 12/13/2007 | WO2007143052A1 Galactosides and thiodigalactosides as inhibitors of pa-il lectin from pseudomonas |
| 12/13/2007 | WO2007143047A1 Uv fluorometric sensor and method for using the same |
| 12/13/2007 | WO2007143037A2 Gene methylation in cancer diagnosis |
| 12/13/2007 | WO2007143034A1 Simultaneous amplification and detection if ribonucleic acid by an optical method using surface plasmon resonance |
| 12/13/2007 | WO2007142945A2 Tracing processes between precursors and products by utilizing isotopic relationships |
| 12/13/2007 | WO2007142908A1 Apparatus and method for separating and concentrating fluids containing multiple components |
| 12/13/2007 | WO2007142781A1 Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof |
| 12/13/2007 | WO2007142695A2 Methods and materials for the detection of leishmania infection |
| 12/13/2007 | WO2007142604A1 Micro thermal cycler with selective heat isolation |
| 12/13/2007 | WO2007142521A1 Testing for sepsis |
| 12/13/2007 | WO2007142402A1 A liver function tester and liver function testing system |
| 12/13/2007 | WO2007142369A1 Method for screening of anti-obesity agent |
| 12/13/2007 | WO2007142347A1 Tumor marker and method for determination of the occurrence of cancerous disease |
| 12/13/2007 | WO2007142336A1 Gene involved in immortalization of human cancer cell and use thereof |
| 12/13/2007 | WO2007142320A1 AMYLOID-β OLIGOMER, METHOD FOR PRODUCTION THEREOF, AND USE THEREOF |
| 12/13/2007 | WO2007142316A1 Method for production of novel nano silica particle and use of the nano silica particle |
| 12/13/2007 | WO2007142314A1 Luminescence enhancer |
| 12/13/2007 | WO2007142309A1 Method of screening drug for treating kidney glomerulus |
| 12/13/2007 | WO2007142276A1 Method for determination of secreted heparin-binding epidermal growth factor-like growth factor |
| 12/13/2007 | WO2007142223A1 Method for diagnosis of hepatocellular carcinoma |
| 12/13/2007 | WO2007142174A1 Container for determining particle agglutination |
| 12/13/2007 | WO2007142139A1 Method of identifying candidate for remedy of acute myeloid leukemia |
| 12/13/2007 | WO2007141974A1 Nonhuman model animal of hypertension |
| 12/13/2007 | WO2007141971A1 Dna encoding polypeptide capable of modulating muscle-specific tyrosine kinase activity |
| 12/13/2007 | WO2007141824A2 Protective container for a device, intended for an underground installation, or an installation immersed in a liquid, and sensor comprising said container |
| 12/13/2007 | WO2007141699A1 Device and method to detect analytes |
| 12/13/2007 | WO2007141691A2 Microelectronic sensor device with washing means |
| 12/13/2007 | WO2007141650A2 Compositions and methods for diagnosing hiv-2 infection |
| 12/13/2007 | WO2007141626A1 Circulating tumor cell assay |
| 12/13/2007 | WO2007141600A1 Current dependent nmda antagonists |
| 12/13/2007 | WO2007141595A2 Method of diagnosing breast cancer using protein markers |